IMPAACT P1115 – Site PI: Prof. Mac Mallewa
Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study
IMPAACT 2008 – Site PI: Prof. Mac Mallewa
Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants
HVTN 805 / HPTN 093 – Site PI: Prof. Johnstone Kumwenda
Antiretroviral analytical treatment interruption (ATI) to assess immunologic and virologic responses in participants who initiated ART in early HIV infection after having received VRC01 or placebo in HVTN 703/HPTN 081
ACTG 5417 – Site PI: Prof. Johnstone Kumwenda
Randomized, Double-Blind, Placebo-Controlled Study of the Combination of two Long-Acting Broadly Neutralizing Antibodies at ART Initiation in Adults Living with HIV-1 in sub-Saharan Africa
IMPAACT 2039 – Site PI: Dr. Sharon Mambiya
EXCEED Trial – Phase I/II Study of the Safety, Immunogenicity, and Efficacy of HIVconsvX Vaccines and Broadly Neutralizing Antibodies in Children Living with HIV